Association of plasma transforming growth factor-β1 levels and the risk of atrial fibrillation: A meta-analysis

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Li, Jiao ^a   Yang, Yajuan ^a   Ng, Chee Yuan ^b   Zhang, Zhiwei ^a   Liu, Tong ^a   Li, Guangping ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; IMMUNOPATHOGENESIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; BLOOD; FEMALE; MALE; META ANALYSIS; MULTIVARIATE ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ATRIAL FIBRILLATION; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84969545696     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155275     Document Type: Article

References (33)

1. Tan AY, Zimetbaum P. Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol 2011; 57:625-9. doi: 10.1097/FJC.0b013e3182073c78 PMID: 21633248
2. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002; 54:361-79. PMID: 12062341
3. Beyerbach DM, Zipes DP. Mortality as an endpoint in atrial fibrillation. Heart Rhythm 2004; 1:B8-19. PMID: 15851134
4. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 2013; 10:90-100. doi: 10.1016/j.hrthm.2012.08.043 PMID: 23063864
5. Everett TH, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007; 4:S24-27. PMID: 17336879
6. Gramley F, Lorenzen J, Koellensperger E, Kettering K, Weiss C, Munzel T. Atrial fibrosis and atrial fibrillation: the role of the TGF-beta1 signaling pathway. Int J Cardiol 2010; 143:405-413. doi: 10.1016/j.ijcard.2009.03.110 PMID: 19394095
7. Redondo S, Navarro-Dorado J, Ramajo M, Medina U, Tejerina T. The complex regulation of TGF-beta in cardiovascular disease. Vasc Health Risk Manag 2012; 8:533-539. doi: 10.2147/VHRM.S28041 PMID: 23028232
8. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-β in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006; 118:10-24. PMID: 16630019
9. Verheule S, Sato T, Everett T, Engle SK, Otten D, Rubart-von der Lohe M, et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res 2004; 94:1458-1465. PMID: 15117823
10. Bunch TJ, Mahapatra S, Bruce GK, Johnson SB, Miller DV, Horne BD, et al. Impact of transforming growth factor-beta1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation 2006; 113:2485-94. PMID: 16717152
11. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994; 271:1615-1619. PMID: 8182815
12. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001; 20:21-35.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560. PMID: 12958120
14. Lin X, Wu N, Shi Y, Wang S, Tan K, Shen Y, et al. Association between transforming growth factor β1 and atrial fibrillation in essential hypertensive patients. Clin Exp Hypertens 2015; 37:82-87. doi: 10.3109/10641963.2014.913600 PMID: 25496287
15. Wu CH, Hu YF, Chou CY, Lin YJ, Chang SL, Lo LW, et al. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation. Heart Rhythm 2013; 10:10-5. doi: 10.1016/j.hrthm.2012.09.016 PMID: 22982967
16. Xiao H, Lei H, Qin S, Ma K, Wang X. TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease. Clin Cardiol 2010; 33:149-156. doi: 10.1002/clc.20713 PMID: 20235205
17. Zhao F, Zhang S, Chen Y, Gu W, Ni B, Shao Y, et al. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation. BMC Cardiovasc Disord 2014; 14:167. doi: 10.1186/1471-2261-14-167 PMID: 25422138
18. Mira YE, Muhuyati, Lu WH, He PY, Liu ZQ, Yang YC. TGF-β1 signal pathway in the regulation of inflammation in patients with atrial fibrillation. Asian Pac J Trop Med 2013; 6:999-1003. doi: 10.1016/S1995-7645(13)60180-7 PMID: 24144036
19. Canpolat U, Oto A, Hazirolan T, Sunman H, Yorgun H, Sahiner L, et al. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy. J Cardiovasc Electrophysiol 2015; 26:251-9. doi: 10.1111/jce.12578 PMID: 25366936
20. On YK, Jeon ES, Lee SY, Shin DH, Choi JO, Sung J, et al. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. J Thorac Cardiovasc Surg 2009; 137:1515-1520. doi: 10.1016/j.jtcvs.2008.10.022 PMID: 19464473
21. Wang Y, Hou X, Li Y. Association between transforming growth factor beta1 polymorphisms and atrial fibrillation in essential hypertensive subjects. J Biomed Sci 2010; 17:23. doi: 10.1186/1423-0127-17-23 PMID: 20356380
22. Kim SK, Pak HN, Park JH, Ko KJ, Lee JS, Choi JI, et al. Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. Europace 2009; 11:1632-1638. doi: 10.1093/europace/eup321 PMID: 19858160
23. Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T, Nishiyama N, et al. Serum Inflammation Markers Predicting Successful Initial Catheter Ablation for Atrial Fibrillation. Heart Lung Circ 2014; 23:636-643. doi: 10.1016/j.hlc.2014.02.003 PMID: 24613042
24. Shim J, Joung B, Park JH, Uhm JS, Lee MH, Pak HN. Long duration of radiofrequency energy delivery is an independent predictor of clinical recurrence after catheter ablation of atrial fibrillation: Over 500 cases experience. Int J Cardiol 2013; 167:2667-2672. doi: 10.1016/j.ijcard.2012.06.120 PMID: 22790188
25. Smit MD, Maass AH, De Jong AM, Muller Kobold AC, Van Veldhuisen DJ, Van Gelder IC. Role of inflammation in early atrial fibrillation recurrence. Europace 2012; 14:810-817. doi: 10.1093/europace/eur402 PMID: 22237586
26. Rosenberg MA, Maziarz M, Tan AY, Glazer NL, Zieman SJ, Kizer JR, et al. Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS). Am Heart J 2014; 16:723-8.
27. Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-beta signaling in fibrosis. Growth Factors 2011; 29:196-202. doi: 10.3109/08977194.2011.595714 PMID: 21740331
28. Kim SK, Park JH, Kim JY, Choi JI, Joung B, Lee MH, et al. High plasma concentrations of transforming growth factor-β and tissue inhibitor of metalloproteinase-1: potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation. Circ J 2011; 75:557-564. PMID: 21186331
29. Arujuna A, Karim R, Caulfield D, Knowles B, Rhode K, Schaeffter T, et al. Acute pulmonary vein isolation is achieved by a combination of reversible and irreversible atrial injury after catheter ablation: evidence from magnetic resonance imaging. Circ Arrhythm Electrophysiol 2012; 5:691-700. doi: 10.1161/CIRCEP.111.966523 PMID: 22652692
30. Rahmutula D, Marcus GM, Wilson EE, Ding CH, Xiao Y, Paquet AC, et al. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-b1. Cardiovasc Res 2013; 99:769-779. doi: 10.1093/cvr/cvt074 PMID: 23612580
31. Zhao F, Zhang S, Shao Y, Wu Y, Qin J, Chen Y, et al. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation. Int J Cardiol 2013; 168:2177-2185. doi: 10.1016/j.ijcard.2013.01.239 PMID: 23465222
32. Zhang YJ, Ma N, Su F, Liu H, Mei J. Increased TRPM6 expression in atrial fibrillation patients contribute to atrial fibrosis. Exp Mol Pathol 2015; 98:486-490. doi: 10.1016/j.yexmp.2015.03.025 PMID: 25796343
33. Wu N, Xu B, Xiang Y, Wu L, Zhang Y, Ma X, et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Int J Cardiol 2013; 25; 169:62-72. doi: 10.1016/j.ijcard.2013.08.078 PMID: 24095158